Comments on ‘Generalized erythroderma and palmoplantar hyperkeratosis in a patient receiving TNF‐alpha antagonist therapy’

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-0560|42|4|295-296

ISSN： 0303-6987

Source： JOURNAL OF CUTANEOUS PATHOLOGY, Vol.42, Iss.4, 2015-04, pp. : 295-296

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost of care for patients with rheumatoid arthritis receiving TNF-antagonist therapy using claims data

By Wu Eric   Chen Lei   Birnbaum Howard   Yang Elaine   Cifaldi Mary  

Current Medical Research and Opinion, Vol. 23, Iss. 8, 2007-08 ,pp. : 1749-1759

Informa Healthcare

Access to resources Recommend Favorite

Lymphocyte Activation with Localized pGL1-TNF-Alpha Gene Therapy in a Glioma Model

By  

Oncology, Vol. 62, Iss. 1, 2002-01 ,pp. : 66-77

Karger

Access to resources Recommend Favorite

Palmoplantar Hyperkeratosis: A Rare Cutaneous Manifestation of Juvenile Dermatomyositis

By  

PEDIATRIC DERMATOLOGY, Vol. 32, Iss. 3, 2015-05 ,pp. : e106-e107

John Wiley & Sons Inc

Access to resources Recommend Favorite

Erythroderma with Generalized Lymphadenopathy Induced by Phenytoin

By  

THE JOURNAL OF DERMATOLOGY, Vol. 16, Iss. 5, 1989-10 ,pp. : 392-396

John Wiley & Sons Inc

Access to resources Recommend Favorite

Priapism in a Patient Receiving Long-Term Chlorpromazine Therapy

By  

Urologia Internationalis, Vol. 71, Iss. 1, 2003-07 ,pp. : 127-128

Karger

Access to resources Recommend Favorite